| Literature DB >> 26345122 |
Holly Ann Williams1, Richard L Dunville2, Susan I Gerber3, Dean D Erdman3, Nicki Pesik4, David Kuhar5, Karen A Mason3, Lia Haynes3, Lisa Rotz4, Jeanette St Pierre3, Sarah Poser3, Sudhir Bunga1, Mark A Pallansch3, David L Swerdlow6.
Abstract
The first ever case of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) was reported in September 2012. This report describes the approaches taken by CDC, in collaboration with the World Health Organization (WHO) and other partners, to respond to this novel virus, and outlines the agency responses prior to the first case appearing in the United States in May 2014. During this time, CDC's response integrated multiple disciplines and was divided into three distinct phases: before, during, and after the initial activation of its Emergency Operations Center. CDC's response to MERS-CoV required a large effort, deploying at least 353 staff members who worked in the areas of surveillance, laboratory capacity, infection control guidance, and travelers' health. This response built on CDC's experience with previous outbreaks of other pathogens and provided useful lessons for future emerging threats.Entities:
Mesh:
Year: 2015 PMID: 26345122 PMCID: PMC4547580 DOI: 10.1177/003335491513000407
Source DB: PubMed Journal: Public Health Rep ISSN: 0033-3549 Impact factor: 2.792